Concave Gold Nanostructures for Ice Recrystallization Inhibition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cryoprotective agents used for organ and tissue preservation are either toxic at high concentrations, ineffective in controlling ice crystal formation within cells, or excessively expensive, leading to limited organ availability and increased organ trafficking due to inadequate preservation methods.

Innovation Solution

The use of Au nanostructures with concave surfaces, which inhibit ice growth by forming a liquid water layer on contact, preventing ice recrystallization and maintaining small ice crystal sizes, thereby enhancing the preservation of cells, tissues, and food by minimizing texture loss during freezing and thawing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If high concentration of permeable CPAs (60% or more) is used to reduce or inhibit ice crystal growth at storage temperature, then antifreezing effect is improved, but tissue toxicity increases

Engineering Contradiction:
Improveantifreezing effectVSAvoidtissue toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces a novel class of CPA compounds that act as intermediaries between the need for ice inhibition and tissue compatibility. These compounds achieve antifreezing effects through a different mechanism than traditional permeable CPAs, allowing effective ice crystal growth inhibition at lower concentrations that are non-toxic to tissues.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the concentration parameter from the traditional 60% or higher requirement down to a much lower range (0.1-10 mM), fundamentally altering the dosage parameters while maintaining or improving antifreezing efficacy through a novel mechanism of action that does not require high concentrations.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If synthetic polymer CPAs are used to control extracellular ice formation, then ice crystal formation is inhibited, but cell membrane penetration is prevented

Engineering Contradiction:
Improveice crystal controlVSAvoidcell membrane penetration
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent creates compounds with specific local properties that allow them to interact with both extracellular and intracellular environments. The molecular structure is designed to provide the necessary interactions for extracellular ice control while simultaneously enabling cell membrane penetration, creating a dual-functional agent.

Inventive Principle:
Principle #3Local quality

3Reliability

If cryoprotective proteins are used to prevent ice formation, then antifreezing effect is improved, but cost and purity become problematic

Engineering Contradiction:
Improveice formation preventionVSAvoidcost and purity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent replaces expensive, difficult-to-purify cryoprotective proteins with small molecule compounds that are chemically synthesizable, stable, and do not require complex purification processes. These small molecules provide comparable or superior antifreezing effects without the manufacturing challenges of protein-based CPAs.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Reliability

If limited preservation time (6-12 hours) is maintained with current methods, then organ quality is preserved, but distribution distance is limited to local areas

Engineering Contradiction:
Improveorgan quality preservationVSAvoidpreservation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies the novel CPA composition to organs immediately after harvest to establish optimal cryoprotection before any preservation or transport process begins. This preliminary treatment ensures that the organ is protected from the outset, enabling extended preservation times and distances without compromising quality.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Au nanostructures effectively prevent ice recrystallization, reducing cell and tissue damage during freezing and thawing, and maintaining food texture, thus addressing the limitations of existing cryoprotective agents by providing a non-toxic and efficient antifreezing solution.

Implementation Method 1

Au nanostructures with concave surfaces, which inhibit ice growth by forming a liquid water layer on contact

Methodology Applied
Scientific EffectFreezing point depression: Phase Change

Implementation Method 2

inhibit ice growth by forming a liquid water layer on contact, preventing ice recrystallization and maintaining small ice crystal sizes

Methodology Applied
Scientific EffectIce recrystallization inhibition: Crystallisation

Data Source

PatentEP3828247B1Use of composition as antifreezing
Publication Date: 2024.03.06 KOREA UNIV RES & BUSINESS FOUND
  • EP3828247B1 patent drawingFigure 1
  • EP3828247B1 patent drawingFigure 2~3
  • EP3828247B1 patent drawingFigure 4

AI summary

The present invention provides a composition for antifreezing including a gold (Au) nanostructure in which at least a portion thereof is concave, thereby it is possible to increase a survival rate of cells due to having excellent effect of inhibiting ice recrystallization when cryopreservation of the cells, and maintain a texture of food even when using in the freezing of food.